The United States Federal R&D Tax Credit Framework

The federal R&D tax credit, formally codified under Section 41 of the Internal Revenue Code (IRC), represents the cornerstone of the United States government’s fiscal policy aimed at incentivizing domestic innovation, technological advancement, and corporate investment in research. The regulatory landscape governing this credit is characterized by immense complexity, requiring taxpayers to navigate a labyrinth of statutory definitions, Treasury Regulations, and extensive substantiation requirements to validate their qualified research expenses (QREs). At the heart of this framework is the rigorous four-part test, which serves as the ultimate gatekeeper for credit eligibility. This test is not applied to a company’s operations broadly; rather, it must be applied separately and strictly to each individual business component. A business component is defined by the code as any product, process, computer software, technique, formula, or invention that the taxpayer intends to hold for sale, lease, or license, or alternatively, to use within their own trade or business operations.

The first hurdle in this evaluation is the Section 174 test, which dictates that the expenditures claimed must be eligible for treatment as research or experimental expenditures under IRC Section 174. Historically, Section 174 permitted taxpayers to immediately expense these developmental costs, providing an immediate tax benefit. However, the landscape shifted dramatically for tax years beginning after December 31, 2021, as taxpayers are now legally required to capitalize and amortize domestic Section 174 research expenses over a five-year period, and foreign research expenses over a fifteen-year period. To satisfy this specific test, the activity must be explicitly intended to discover information that eliminates technical uncertainty regarding the capability or method of developing the business component, or the appropriateness of its final design.

Following this is the discovering technological information test, which mandates that the research must fundamentally rely on the principles of the hard sciences. Specifically, the underlying activities must be rooted in the physical sciences, biological sciences, engineering, or computer science. The Internal Revenue Service explicitly excludes any research based on the soft sciences, such as economic, psychological, or sociological research, regardless of how innovative or uncertain the outcome might be. The third prong, the business component test, requires that the application of the information discovered during the research phase must be intended to be useful in the development of a new or improved business component for the taxpayer. The primary focus here is on achieving a demonstrable improvement in the functionality, performance, reliability, or quality of the component in question, completely excluding activities aimed merely at cosmetic changes or style variations.

The final and often most intensely scrutinized requirement is the process of experimentation test. The statutory language demands that substantially all of the research activities must constitute elements of a process of experimentation directed toward a qualified purpose. Treasury Regulations have quantified “substantially all” as meaning that eighty percent or more of the taxpayer’s research activities for that specific component must meet the experimentation criteria. This process is not a casual trial-and-error endeavor; it requires the systematic identification of technical uncertainty, the formulation of one or more hypotheses or alternatives intended to eliminate that uncertainty, and the rigorous execution of iterative testing, modeling, or simulation to evaluate those alternatives. If the business component does not reach this minimum threshold, the company must apply the test at the next sub-level of the business component, a concept known as the shrink-back rule.

Within the federal framework, software development introduces a unique layer of regulatory complexity. The tax code inherently views internal use software (IUS)—defined as software developed primarily for the taxpayer’s internal general and administrative functions, such as financial management, human resources, or inventory tracking—with significant skepticism. Consequently, IUS is generally excluded from credit eligibility unless it satisfies an arduous three-part High Threshold of Innovation (HTI) test. The issuance of Final Regulations (T.D. 9786) in 2016 provided critical clarity on this front, establishing that to pass the HTI test, the software must be highly innovative, meaning it results in a reduction of cost or improvement in speed that is substantial and economically significant. Furthermore, the development must involve significant economic risk, wherein the taxpayer commits substantial resources while facing significant technical uncertainty regarding whether those resources can be recovered within a reasonable timeframe. Finally, the software must not be commercially available for use without significant, technically challenging modifications. Crucially, T.D. 9786 clarified that software developed to interact with third parties, such as platforms enabling external customers or vendors to initiate functions or review data on the taxpayer’s systems, is explicitly excluded from the strict IUS definition and therefore only needs to meet the standard four-part test.

The administrative enforcement of the federal R&D credit has become increasingly stringent. Recent revisions to IRS Form 6765, particularly the introduction of Section G, now mandate exhaustive qualitative and quantitative disclosures for every single business component claimed. Furthermore, a 2021 Chief Counsel Memorandum (CCM 20214101F) established that taxpayers must meticulously document all research activities performed, identify the specific individuals who performed each activity, and articulate the exact technical information each individual sought to discover for every business component. This level of granular reporting effectively eliminates the viability of high-level estimations and places a profound documentation burden on the taxpayer.

Federal R&D Tax Credit Jurisprudence and Case Law Analysis

Judicial interpretation plays an outsized role in defining the practical boundaries of IRC Section 41. Recent decisions from the United States Tax Court and federal appellate courts have provided critical guidance on substantiation, the definition of experimentation, and the allocation of contractual risk.

The 2014 landmark Tax Court case of Suder v. Commissioner serves as a foundational precedent regarding the substantiation of QREs, particularly concerning executive compensation. In this case, the IRS aggressively challenged the reasonableness of the massive wages claimed by the CEO of ESI, a telecommunications equipment developer, asserting that his compensation was excessive and improperly classified as research expenses. The Tax Court, however, ruled favorably for the taxpayer, heavily emphasizing that the CEO spent the vast majority of his time directly engaged in developing hardware and software concepts, designing prototypes, and solving complex technical bugs. The ruling validated the taxpayer’s methodology of utilizing a third-party R&D study combined with extensive interviews of senior management to allocate precise wage percentages to qualified projects. The court found that the iterative process of alpha testing by internal engineers and beta testing by customers—wherein prototypes were provided at a discount in exchange for performance feedback—perfectly exemplified the resolution of technical uncertainty required by the statute.

Conversely, the 2019 decision in Siemer Milling Co. v. Commissioner serves as a stark warning regarding the rigorous requirements of the process of experimentation test. Siemer, a family-owned wheat milling enterprise, claimed R&D credits for several product and process improvements, most notably a project aimed at developing a heat-treated flour product. The Tax Court entirely disallowed the claimed credits, concluding that the company’s developmental activities completely lacked a systematic scientific method. The court determined that Siemer’s efforts largely consisted of tweaking operational parameters, such as adjusting oven temperatures on the production line, which more closely resembled routine quality control and standard trial-and-error troubleshooting rather than a true process of experimentation relying on the principles of biological or physical sciences. The documentation provided was deemed fatally vague, failing to establish the formulation of hypotheses or the rigorous analysis of experimental outcomes. Although the credits were denied, the court declined to impose accuracy-related penalties because the company had acted in good faith by relying on experienced accountants.

The complex realm of contract research is governed by the funded research exclusion, which denies the credit if a taxpayer does not retain substantial rights to the research results or does not bear the economic risk of failure. In the 2024 case of Meyer, Borgman & Johnson, Inc. v. Commissioner, the Eighth Circuit Court of Appeals affirmed the Tax Court’s denial of R&D credits for a structural engineering firm. Upon meticulous analysis of the firm’s client contracts, the court determined that the firm’s right to payment was not strictly contingent on the success of the research; the firm was generally paid for its services regardless of whether the specific structural designs succeeded, meaning the client, not the engineering firm, bore the ultimate economic risk. Similarly, in Enercon Engineering, Inc. v. Commissioner, the court disallowed nearly one million dollars in credits because the taxpayer, operating as a contractor for a third party, failed to establish through its contractual agreements that it retained substantial rights to the intellectual property generated from its engineering work. The regulations explicitly state that amounts payable under any agreement that are contingent on the success of the research are not treated as funding, placing the burden on the taxpayer to ensure contract language clearly reflects this allocation of risk.

The procedural aspects of defending an R&D claim during an IRS examination were addressed in the 2024 case of Kapur et al. v. Commissioner. A civil engineering firm claimed credits based on a statistical sampling frame of over two thousand projects. During discovery, the taxpayer attempted to limit the IRS’s review to only the two largest projects in the sample, arguing that reviewing the entire population was disproportionate to the tax amount in controversy. The Tax Court firmly denied this request, ruling that evaluating compliance with Section 41 inherently requires a comprehensive consideration of the underlying business components, and the IRS is entitled to preliminary information on the entire sampling frame to verify the statistical validity of the claim.

The State of Michigan R&D Tax Credit Landscape

Recognizing the economic imperative of localized innovation, the Michigan legislature enacted Public Acts 186 and 187 of 2024, reinstating a state-level R&D tax credit for the first time since the repeal of the Michigan Business Tax in 2012. The elimination of the previous credit had been viewed as a significant detriment to the state’s competitiveness, particularly for research-intensive clusters like biosciences. Effective for tax years beginning on or after January 1, 2025, this new legislation establishes a highly structured, refundable incentive program aimed at bolstering economic growth and strengthening technology ties across the private sector and educational institutions.

The statutory framework meticulously aligns its definition of qualifying research and development expenses (MQREs) directly with IRC Section 41(b), meaning that federal eligibility is an absolute prerequisite. However, the crucial geographic caveat is that only expenses incurred for research activities physically conducted within the boundaries of the state of Michigan are eligible. The program operates under an annual statewide aggregate cap of $100 million, out of which $25 million is explicitly reserved for small businesses, ensuring that early-stage enterprises are not crowded out by massive corporate claims.

The calculation of the Michigan credit utilizes a base amount methodology defined as the average annual MQREs incurred during the three calendar years immediately preceding the calendar year ending with or within the tax year for which a credit is being claimed. For claimants with fewer than three years of historical expenses, the Department of Treasury provides specific adjustments to normalize the base. Notably, unlike the federal Alternative Simplified Credit (ASC), which reduces the base amount to fifty percent of the three-year average, Michigan utilizes the full unadjusted average in its calculation.

The credit is tiered based on the size of the employer, with distinct statutory caps imposed on the maximum allowable claim per taxpayer:

Table 1: Michigan R&D Tax Credit Tier Structure (Public Acts 186 and 187 of 2024)

A defining and unique feature of the Michigan legislation is a structural incentive designed explicitly to foster academic-industrial partnerships. Both large and small taxpayers who incur MQREs in collaboration with a Michigan research university—statutorily defined as a public university under the state constitution or an independent nonprofit college in the state—are eligible for an additional five percent credit on expenses that exceed the base amount. This bonus is capped at $200,000 annually per taxpayer and requires a formal, written contractual agreement between the business and the university to be in place, promoting knowledge-sharing and the commercialization of academic research.

The Michigan Department of Treasury has outlined strict administrative procedures for claiming the credit, differentiating the process based on entity type. Public Act 186 addresses Corporate Income Tax (CIT) taxpayers, while Public Act 187 addresses flow-through entities—such as S corporations—that are employers subject to Michigan income tax withholding. This mechanism allows flow-through entities to claim the credit directly against the taxes required to be withheld and remitted to the state, providing highly advantageous immediate liquidity. For Unitary Business Groups (UBGs) operating under the CIT, the group itself is considered the taxpayer, meaning that eligibility, cap limitations, and base amounts are determined based on an aggregate calculation of the entire UBG’s R&D expenses.

Crucially, taxpayers must formally notify the state of their intent to claim the credit by filing a tentative claim through Michigan Treasury Online (MTO). For expenses incurred in the 2025 calendar year, this tentative claim is due no later than April 1, 2026. This deadline is statutory and absolute; the Treasury has explicitly stated it will not accept late submissions. Because these tentative claims dictate the aggregate demand for the credit, they must rely on actual expenses rather than estimates. Following the submission deadline, the Treasury will determine if the aggregate tentative claims exceed the $100 million statutory cap. If the cap is breached, the Treasury will issue a general notice on its website specifying the required proration adjustment for each type of claimant, effectively reducing the allowed credit across the board. For tax years subsequent to 2025, the tentative claim deadline is accelerated to March 15 of the following year.

The Economic Genesis and Industrial Evolution of Lansing, Michigan

To fully contextualize the application and impact of these R&D tax credits, it is essential to understand the unique economic geography and historical trajectory of Lansing, Michigan. The city’s industrial evolution is a continuous narrative of reinvention, transitioning from heavy automotive manufacturing to a highly diversified, knowledge-based regional economy.

Lansing’s origins are deeply unconventional, rooted in a speculative land scam in 1835 known as Biddle City. Two brothers plotted land in a floodplain area that is now REO Town, scamming investors into buying submerged, forested plots. Despite the fraudulent beginnings, a group of settlers remained, eventually forming Lansing Township. The settlement’s fortunes changed dramatically in 1847 when, due to geopolitical maneuvering to find a secure, central location away from the Canadian border and the dominant influence of Detroit, the state legislature designated the small township as Michigan’s new capital.

The industrial trajectory of the city was permanently catalyzed in 1897 when Ransom E. Olds drove his first automobile down its streets and subsequently founded the Olds Motor Vehicle Company. He later established the REO Motor Car Company, cementing a long-standing, defining relationship between Lansing and the global automotive industry. Throughout the twentieth century, supported by massive infrastructure investments like the Fisher Body plant, Lansing transformed into a global epicenter for manufacturing automobiles and parts, driving its population from roughly 16,000 in 1900 to over 100,000 by 1960.

However, as the traditional automotive industry restructured and consolidated in the late twentieth century, Lansing faced the economic stagnation and job losses common to the industrial Rust Belt. Recognizing the dangers of an overreliance on a single sector, regional leadership undertook aggressive diversification efforts. Guided by strategic initiatives from organizations like the Lansing Economic Area Partnership (LEAP) and the immense, specialized intellectual capital generated by neighboring Michigan State University (MSU) in East Lansing, the regional economy evolved rapidly. Today, while retaining its manufacturing heritage, Lansing operates as a resilient regional hub characterized by specialized, high-growth industry clusters: advanced manufacturing and electric mobility, insurance services and InsurTech, biotechnology and life sciences, advanced materials, and agricultural food technology.

Lansing Industry Case Studies and Tax Credit Eligibility

The following exhaustive case studies illustrate how specific industries, deeply rooted in Lansing’s distinct economic history, can leverage both the federal IRC Section 41 credit and the newly reinstated Michigan state R&D tax credit to offset the massive costs of innovation.

Case Study: Advanced Manufacturing and Electric Vehicle Battery Technology

The modern advanced manufacturing sector in Lansing is a direct descendant of its REO and Oldsmobile lineage. The region successfully retained a highly skilled, unionized workforce and an ingrained culture of heavy industrial production. Recognizing this heritage and the established logistics infrastructure, General Motors and LG Energy Solution formed a joint venture, Ultium Cells, initiating a historic $2.6 billion investment in a 2.8 million-square-foot facility in Delta Township, bordering Lansing. This facility, which is transitioning entirely to LG Energy Solution’s management in 2025, represents a monumental shift from internal combustion engines to electric vehicle (EV) mobility, supported by extensive workforce training partnerships with Lansing Community College and Capital Area Michigan Works!.

To remain competitive globally, an advanced EV battery manufacturer in Lansing must engage in continuous, high-risk R&D to improve battery cell energy density. A primary research vector involves developing advanced NCMA (nickel-cobalt-manganese-aluminum) chemistries that utilize seventy percent less cobalt while maintaining thermal stability during rapid charging. The company establishes a dedicated research team in Lansing to scale this delicate chemical formulation for mass factory production.

Under the federal IRC Section 41 framework, this activity solidly qualifies. The Section 174 test is met as the company expends capital to eliminate severe technical uncertainty regarding the scale-up dynamics of the NCMA process, a task fraught with risks of thermal runaway or chemical degradation. The technological information test is satisfied through direct reliance on chemical engineering and metallurgy. To satisfy the rigorous process of experimentation test, the manufacturer must meticulously document iterative cycles of mixing, coating, and thermal testing of battery slurry, recording the scientific parameters of both successful formations and failed cells. Furthermore, under the Inflation Reduction Act of 2022 (IRC Section 30D), successfully optimizing and assembling these battery components in North America provides parallel consumer tax incentives—up to $3,750 for meeting the Battery Component Requirement—which compounds the strategic commercial value of the underlying R&D.

Applying the Michigan state eligibility framework, assume this manufacturer employs 1,500 workers, classifying it as a Large Business under Public Act 186. Furthermore, they contract with the MSU College of Engineering to utilize their advanced electron microscopes to analyze atomic-level degradation in the NCMA cathodes.

Table 2: Hypothetical Michigan R&D Credit Calculation for an EV Battery Manufacturer

Case Study: Insurance Services and InsurTech

Beyond manufacturing, Lansing has evolved into a formidable insurance metropolis, serving as the national or regional headquarters for massive entities such as Auto-Owners Insurance, Jackson National Life, AccidentFund, and Michigan Millers. This cluster developed primarily because Lansing is the state capital, providing these highly regulated corporations direct, immediate access to legislative bodies and the Department of Insurance and Financial Services. Furthermore, during the 1990s administration of Governor John Engler and Insurance Commissioner D. Joseph Olson, Michigan aggressively deregulated its insurance market, shifting from burdensome government price-fixing mandates to a competitive free-market approach. This highly favorable, modernized regulatory climate attracted immense capital, transforming legacy regional carriers into modern financial technology (InsurTech) powerhouses.

In this environment, a major Lansing life insurance company invests heavily in developing a proprietary, artificial intelligence-driven actuarial underwriting platform. This system is designed to dynamically price annuity risk based on real-time macroeconomic data, similar to the advanced technological architectures required to integrate products into platforms like SIMON from iCapital.

For federal R&D credit purposes, software development within financial services frequently triggers the complex Internal Use Software (IUS) rules. If the software is developed primarily for internal administrative functions, such as automating back-office accounting, it faces the arduous High Threshold of Innovation (HTI) test. However, following the clarifications in T.D. 9786, if the platform is designed to allow independent brokers and third-party financial advisors to initiate transactions, dynamically price annuities, and review client data directly over the web, it is explicitly exempted from the IUS classification and its associated burdens. Even if segments of the code are classified as IUS, utilizing advanced machine learning algorithms to predict mortality and market risk involves profound technical uncertainty and relies heavily on computer science, thus satisfying the four-part test, provided the economic risk of the development project failing is substantial. Eligible expenses in this scenario would prominently include cloud computing fees (e.g., AWS or Azure environments used specifically for development) and the W-2 wages of software engineers and data scientists. Taxpayers must be cautious, however, to align their financial statement treatment of these software development costs with their tax accounting methods under Section 174 to ensure compliance.

Applying the Michigan state eligibility framework, consider a mid-sized InsurTech firm based in downtown Lansing with 150 employees, categorizing it as a Small Business. They expand their engineering team significantly to build a new platform. If their current year MQREs are $3,000,000 against a historical base amount of $1,000,000, their state credit calculation initially yields $30,000 on the base amount (3%) and $300,000 on the excess amount (15%). However, because they are statutorily defined as a small business subject to a hard $250,000 cap, their maximum allowable tentative claim on their Michigan CIT return is strictly limited to $250,000, regardless of the formulaic outcome.

Case Study: Biotechnology and Rare Isotope Research

Lansing’s biotechnology and life sciences cluster possesses a unique and highly localized origin story. In 1982, the W.K. Kellogg Foundation, recognizing the urgent need to diversify Michigan’s economy away from pure automotive dependence, granted $10 million to help establish the Michigan Biotechnology Institute (MBI). MBI’s mission was to link university research with commercial applications, pioneering a process of “de-risking” technologies to quickly fail flawed concepts while scaling viable ones, leading to innovations like bio-based polymers (PLA) and synthetic spider silk. Concurrently, decades of advanced physics research at MSU culminated in the U.S. Department of Energy establishing the Facility for Rare Isotope Beams (FRIB) on the MSU campus. This $730 million superconducting linear accelerator, which recently received a $49.7 million upgrade, accelerates nuclei to over half the speed of light, smashing targets to produce exotic, short-lived isotopes, positioning the region at the absolute global forefront of nuclear medicine and astrophysics.

A Lansing-based biopharmaceutical startup leverages this proximity by utilizing specific radioactive isotopes harvested from FRIB to develop novel, targeted radioligand therapies for rare, previously untreatable forms of neuroendocrine tumors.

This deep-science research undeniably meets the Section 41 four-part test, as it relies fundamentally on nuclear physics and human biology to develop a new biological business component through rigorous, highly regulated clinical trials. However, the paramount strategic tax advantage in this specific field is the intersection with the Orphan Drug Tax Credit (IRC Section 45C). If the FDA officially grants orphan drug designation for this rare disease treatment, the company can claim a powerful, nonrefundable 25% federal credit on its Qualified Clinical Testing Expenses (QCTEs). Proper tax structuring is critical here: while a company can legally claim both the Section 41 R&D credit and the Section 45C Orphan Drug credit in the exact same tax year, they are prohibited from claiming both credits on the exact same expenditure dollar, requiring meticulous cost segregation protocols during the clinical trial phases.

When applying for the Michigan state credit, this biotech firm must carefully evaluate the funded research provisions highlighted in cases like Meyer, Borgman. If the startup conducts research funded by grants from the Department of Energy or the National Institutes of Health, and the government retains rights to the data or the startup is not financially at risk if the trials fail, those specific expenses are excluded from both federal QREs and Michigan MQREs. Conversely, if the research is funded by private venture capital where the startup retains the patents and bears the risk of total capital loss, the expenses qualify. If the startup contracts with MSU’s specialized In Vivo Facility to perform essential toxicology and pharmacology assays, the payments made to the university would qualify as contract research expenses at the federal level and would immediately trigger Michigan’s highly valuable 5% university collaboration bonus.

Case Study: Synthetic Diamond and Semiconductor Materials

The global semiconductor supply chain is facing an existential crisis as traditional silicon reaches its physical limits in managing extreme temperatures and high voltages. Michigan State University’s College of Engineering anticipated this bottleneck, spending over three decades perfecting the complex laboratory growth of synthetic diamonds. These diamonds are not for jewelry; they possess exceptionally high thermal conductivity—exponentially higher than copper—making them the ideal substrate for next-generation electronics. This intense academic research was recently commercialized through a spinoff entity, Great Lakes Crystal Technologies (GLCT), operating in deep partnership with the Fraunhofer USA Center Midwest in Lansing. This highly specialized ecosystem forms the core of the region’s current bid for an Economic Development Administration (EDA) Tech Hub designation for the Hub for Materials Advancement and Research Solutions (MARS).

A Lansing materials science firm operating in this cluster attempts to scale the commercial production of high-voltage diamond semiconductors using a highly complex process known as microwave plasma chemical vapor deposition. Growing diamond films layer-by-layer without introducing microscopic lattice imperfections, such as cracks or elemental impurities, presents massive, persistent technical uncertainty.

Federal case law, specifically the Suder v. Commissioner decision, provides a robust framework for maximizing the credit in this hardware-intensive environment. Just as the CEO in Suder successfully claimed substantial wages as QREs for personally designing prototypes and analyzing beta testing feedback, the lead materials engineers and executive founders in this Lansing firm can claim a significant percentage of their W-2 wages. Their eligible time includes designing the physical microwave plasma chambers, conducting structural integrity testing on the diamond wafers using advanced photon beams, and iterating the chemical lattice-etching formulas utilizing boron and phosphorus doping. The process of experimentation test is inherently and deeply satisfied as the company iteratively adjusts plasma temperature, atmospheric pressure, and dopant concentration levels to achieve perfect crystallization, rigorously analyzing every microscopic failure.

Because this firm is a direct spin-off utilizing licensed patents and facilities originating from MSU, their ongoing physical R&D expenditures are heavily intertwined with the university’s infrastructure. By establishing a formal, written R&D agreement for shared access to the Fraunhofer cleanroom space or joint testing protocols with university faculty, the company can maximize the Michigan 5% university collaboration credit. For a rapidly growing, capital-intensive firm with 50 employees, aggressively leveraging this state credit provides critical non-dilutive capital, essential for bridging the commercialization “valley of death” inherent in deep-tech semiconductor manufacturing.

Case Study: Agricultural and Food Processing Technology

Michigan State University was established in 1855 as the nation’s premier agricultural land-grant institution, and that legacy continues to shape the Lansing regional economy. In 1928, cereal magnate W.K. Kellogg deeded his expansive farm to the college to serve as a perpetual object lesson in modern agricultural management, establishing purebred dairy herds and advanced cropping systems. This legacy evolved seamlessly into the creation of the MSU Product Center and, more recently, the MSU Food Processing and Innovation Center (FPIC) located in Okemos, a suburb of Lansing. The FPIC operates as a fully licensed USDA and FDA commercial food development facility, allowing food processors, agricultural tech companies, and startups to scale up recipes, test thermal thresholds, and pilot new packaging in a highly controlled, risk-mitigated environment before committing to massive factory expansions. During the COVID-19 pandemic, the facility even repurposed its commercial ovens to research the heat-treatment decontamination of N95 masks, demonstrating its versatile scientific capabilities.

A regional food manufacturer utilizes the FPIC to develop a novel thermal pasteurization process intended to dramatically extend the ambient shelf life of a highly sensitive dairy product without degrading its essential nutritional profile or complex flavor notes.

In the food processing sector, distinguishing legally qualified research from non-qualified routine quality control is a perilous endeavor. The Tax Court decision in Siemer Milling Co. v. Commissioner serves as a critical, binding warning. In Siemer, the flour company claimed R&D credits for a heat-treatment process, but the court ruthlessly denied the claims because the activities lacked a true, systematic scientific process of experimentation; the company merely adjusted oven temperatures without documenting formal hypotheses or analyzing the biochemical principles of the resulting failures.

To avoid the costly Siemer trap, the Lansing food manufacturer must meticulously document their methodology. They cannot simply run informal trial-and-error batches to see what tastes acceptable. They must establish formal technical uncertainties prior to testing (e.g., predicting protein denaturation rates at specific thermal loads), propose scientifically grounded hypotheses relying on microbiology and food chemistry, conduct strictly controlled trials at the FPIC, and rigorously analyze the microbial degradation and rheological properties of both failed and successful batches using laboratory assays.

By conducting these highly documented, scientifically valid trials at the MSU-operated FPIC, the manufacturer ensures their activities fall squarely within Michigan’s borders, satisfying the strict geographic requirement for state MQREs. Furthermore, if the food company is structured as a flow-through entity, such as an S-Corporation or an LLC, under Public Act 187, they will claim the Michigan R&D credit directly against the taxes they are required to withhold and remit for their employees. This mechanism is profoundly advantageous, providing immediate, liquid cash flow benefits in real-time, rather than forcing the company to wait until year-end to offset future corporate income tax liabilities.

Table 3: Michigan R&D Credit Administrative Mechanisms by Entity Type

Strategic Synthesis and Compliance Best Practices

The intersection of federal tax law and the newly reinstated Michigan R&D tax credit creates a highly lucrative but procedurally demanding environment for Lansing-based businesses seeking to subsidize their technological evolution.

At the federal level, the Internal Revenue Service is enforcing an era of unprecedented scrutiny and documentation demands. Revisions to IRS Form 6765, specifically the implementation of Section G, now mandate exhaustive qualitative and quantitative disclosures for every single business component claimed. Taxpayers can no longer rely on high-level estimates or generalized project descriptions. They must contemporaneously document the specific research activities performed, identify the exact individuals conducting the research, and clearly articulate the precise technical uncertainties sought to be eliminated for each distinct project. In litigation, as demonstrated by the Kapur decision, the Tax Court will absolutely not permit taxpayers to arbitrarily limit IRS discovery to a handful of representative projects; statistical sampling must be rigorously scientific, and underlying empirical data for all components within the sampling frame must be meticulously maintained and produced upon request. Furthermore, companies engaging in software development must carefully navigate the interplay between Section 41 eligibility and their chosen method of accounting under Section 174, ensuring alignment between their financial statements and tax filings.

At the state level, the Michigan Department of Treasury’s implementation of Public Acts 186 and 187 introduces a strict, unyielding timeline risk that corporate financial officers must vigilantly manage. The statutory requirement to file a tentative claim by April 1, 2026 (for expenses incurred in calendar year 2025) via the Michigan Treasury Online portal is absolute. Failure to successfully submit this tentative claim, or submitting it based on inaccurate estimates rather than finalized actual expenses, will result in the total forfeiture of the state credit, regardless of the scientific validity or economic value of the underlying research.

Furthermore, the $100 million aggregate state cap virtually guarantees that claims will be subject to proration. Corporate tax planners and CFOs must proactively model this proration risk into their cash flow projections; a large business mathematically eligible for a $2 million maximum credit under the statutory formula may receive a significantly lower adjusted amount once the Treasury aggregates statewide tentative claims and issues final adjustment notices.

Lansing’s incredibly diverse industrial clusters—ranging from the heavy engineering of EV batteries and the complex algorithms of InsurTech to the deep, fundamental science of rare isotopes and synthetic diamonds—are uniquely positioned to capture these dual incentives. By intentionally aligning their historical manufacturing prowess with rigorous, highly documented scientific methodologies and strategic academic partnerships, industries throughout Mid-Michigan can effectively subsidize their ongoing technological evolution while remaining strictly compliant with an increasingly complex and unforgiving tax jurisprudence.